http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102311448-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_994f120b7f85530a1c712cfddf6625c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90348a429ffa25bbd39a647ab0d9173e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d1490cb35bcbbd60f0ba859fc96029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4e0fe726a9e08596af5e0b83a49c40f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e3bb0ff174d524d8f7d51e8194fae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bd24d69fc96b0452a454a1e62cc9df5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c448d05e76a23e95605d7f5f79ef529
publicationDate 2012-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102311448-A
titleOfInvention Thienopyrimidinone DPP-IV Inhibitors
abstract The invention belongs to the technical field of medicine, and in particular relates to compounds or salts thereof with thienopyrimidinone as the core nucleus, their preparation methods, compositions and such compounds as dipeptidyl peptidase (DPP-IV) inhibitors in the prevention or treatment of Use in the treatment of a disease that would benefit from inhibition of DPP-IV. The preparation process of the compound of the present invention is simple, the raw materials are easy to obtain, and it is suitable for large-scale industrial production. It has been verified by in vitro experiments that it has a very good selective inhibitory effect on DPP-IV. While effectively inhibiting the activity of DPP-IV, it also inhibits DPP-IV The activities of VIII and DPP-IX have almost no influence, and it can be predicted that the toxicity of the compound of the present invention will be very low after being developed into medicine, which has outstanding advantages.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021027943-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103755601-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730742-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014323466-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019170157-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9045491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109134492-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013078765-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103130819-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022242697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106866678-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109134492-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022237875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103755601-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103130819-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015500211-A
priorityDate 2010-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008066664-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004122228-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466069313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123426628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466142972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152954601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467453478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466146905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49785099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465240783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148695160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468317787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467501887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467808258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411756647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423583582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57384835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466102464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414424634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425303471

Total number of triples: 60.